China Approves NEO Brain Chip for Paralysis Patients, Advancing 2030 BCI Industry Push
Updated
Updated · Fox News · Jun 19
China Approves NEO Brain Chip for Paralysis Patients, Advancing 2030 BCI Industry Push
3 articles · Updated · Fox News · Jun 19
Summary
China cleared NEO for commercial medical use in some patients with spinal cord injury-related paralysis, marking what the report describes as the world’s first approved commercial brain-computer interface.
NEO, developed by Tsinghua University and Shanghai-based Neuracle Technology, sits under the skull on the dura mater rather than penetrating brain tissue, a design intended to reduce invasiveness while translating motor signals into device commands.
The initial use is narrow: helping severely paralyzed patients control tools such as robotic gloves, prosthetic hands or computer interfaces with their thoughts, moving the technology beyond research trials toward clinical care.
The approval also sharpens competition with Neuralink, which has implanted devices in more than 20 trial participants but still lacks broad FDA clearance for general commercial use.
China’s move fits a wider state-backed plan to achieve brain-computer interface breakthroughs by 2027 and build a globally competitive industry by 2030, even as privacy and cybersecurity concerns over neural data intensify.
Is China’s less-invasive brain chip a true rival or a compromise on performance for faster approval?
As brain chips go commercial, who will own your neural data and how can it be protected?
Will brain-computer interfaces create a new era of healing or a new form of human inequality?
China Approves First Commercial Brain Chip for Paralysis: The NEO Device and the Race for BCI Supremacy
Overview
In March 2026, China became the first country to approve the NEO brain chip, a coin-sized brain-computer interface designed to help people with severe paralysis regain hand movement. Unlike more invasive devices, the NEO chip is placed on the dura mater, a protective membrane of the brain, which helps reduce surgical risks. The chip records electrical signals from neurons and translates them into commands to control a robotic glove, allowing patients to perform daily tasks. This breakthrough marks a major step in making advanced neurotechnology available outside clinical trials, offering new hope for improved independence and quality of life.